Science Explorer Interactive view Map
Company · Boston · United States

Pieris Pharmaceuticals (United States)

pieris.comROR OpenAlex
Research works
61
▲ 11% vs 2013–17
Citations
531
8.7 per fractional work
Top-10% rate
21.2%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Pieris Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.92× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.85× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.77× its world share, 0 worksImmunology and Micro…Computer Science: 1.38× its world share, 2 worksComputer ScienceEnergy: 2.48× its world share, 0 worksEnergyEngineering: 0.95× its world share, 2 worksEngineeringMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 0.19× its world share, 0 worksMathematicsPhysics and Astronomy: 0.51× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.74× its world share, 1 worksHealth ProfessionsMedicine: 1.41× its world share, 4 worksMedicineNursing: 1.86× its world share, 0 worksNursingVeterinary: 3.35× its world share, 0 worksVeterinaryArts and Humanities: 1.95× its world share, 1 worksArts and HumanitiesDecision Sciences: 1.18× its world share, 0 worksDecision SciencesPsychology: 0.87× its world share, 0 worksPsychologySocial Sciences: 1.12× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 3.4×. Every wedge is a field page.

Which keywords describe research at Pieris Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Combustion, Chemical Kinetics, Soot Formation, Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Cancer Immunotherapy and Antibody Engineering.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology4▲ 1.51×10 topics
  2. Combustion3▲ 77×2 topics
  3. Chemical Kinetics3▲ 44×1 topic
  4. Soot Formation3▲ 103×1 topic
  5. Sustainability3▲ 2.6×8 topics
  6. Treatment3▲ 3.4×5 topics
  7. Monoclonal Antibodies3▲ 30×3 topics
  8. Genetics2▲ 5.4×3 topics
  9. Renewable Energy2▲ 4.1×8 topics
  10. Therapeutic Antibodies2▲ 32×2 topics
  11. Glycosylation2▲ 18×2 topics
  12. Immunotherapy2▲ 5.9×5 topics
  13. Inflammation2▲ 1.71×5 topics
  14. Cancer Immunotherapy2▲ 27×2 topics
  15. Sustainable Development2▲ 3.2×8 topics
  16. Antibody Engineering2▲ 36×1 topic
  17. Fc Receptors2▲ 36×1 topic
  18. Asthma2▲ 28×2 topics
  19. Allergic Diseases2▲ 43×1 topic
  20. Eosinophils2▲ 43×1 topic
  21. Environmental Impact2▲ 2.4×6 topics
  22. Tumor Regression2▲ 36×2 topics
  23. Hydraulic Systems2▲ 51×2 topics
  24. Eco-Driving2▲ 60×1 topic
  25. Fuel Consumption2▲ 46×1 topic
  26. CAR T Cells2▲ 59×1 topic
  27. Chimeric Antigen Receptor2▲ 59×1 topic
  28. Lymphoma2▲ 18×2 topics
  29. Adaptive1▲ 42×1 topic
  30. Archaeology1▲ 14×3 topics
  31. Community Participation1▲ 9.0×2 topics
  32. Control1▲ 16×1 topic
  33. Mediterranean1▲ 21×2 topics
  34. Urbanization1▲ 7.1×2 topics
  35. Medieval Architecture1▲ 91×2 topics
  36. Health Equity1▲ 9.4×2 topics
  37. Palliative Care1▲ 10×2 topics
  38. Renewable Resources1▲ 13×3 topics
  39. Signal Processing1▲ 13×3 topics
  40. Targeted Therapy1▲ 7.7×4 topics

Which research topics does Pieris Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Information Science and Libraries and Historical and Literary Studies.

Monoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCAR-T cell therapy research: 1 fractional worksInformation Science and …0Information Science and Libraries: 0 fractional worksHistorical and Literary …0Historical and Literary Studies: 0 fractional worksGlobal Energy and Sustainability Research: 0 fractional worksAgriculture and Farm Safety: 0 fractional worksHistory of Science and N…0History of Science and Natural History: 0 fractional worksAnimal Disease Management and Epidemiology: 0 fractional worksVector-Borne Animal Diseases: 0 fractional worksCultural Heritage Manage…0Cultural Heritage Management and Preservation: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyInformation SystemsAnthropology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Information Science and Libraries Information Systems 0 works
  4. 4 Historical and Literary Studies Anthropology 0 works
  5. 5 Global Energy and Sustainability Research Renewable Energy, Sustainability and the Environment 0 works
  6. 6 Agriculture and Farm Safety Plant Science 0 works
  7. 7 History of Science and Natural History History and Philosophy of Science 0 works
  8. 8 Animal Disease Management and Epidemiology Agronomy and Crop Science 0 works
  9. 9 Vector-Borne Animal Diseases Ecology, Evolution, Behavior and Systematics 0 works
  10. 10 Cultural Heritage Management and Preservation Archeology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.1%not open65.9%

World: 28% of research is openly available.

with international co-authors41.6%domestic only58.4%

World: 19% is written across borders.

How has Pieris Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 11% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.